@inproceedings{inproceedings, title  = {{Denosumab suppresses bone turnover markers in breast cancer patients (PTS) with bone metastases (METS) naive to intravenous bisphosphonates (IV BP) regardless of antineoplastic treatment}},

 url = {{}},

 year = {{2006}},

 month = {{9}},

 author = {{Steger GG and Body JJ and Solal-Celigny P and Berardi R and Gascon P and Fan M and Kinsey A and Jun S and Coleman R}},

 volume = {{17}},

 journal = {{ANNALS OF ONCOLOGY}},

 pages = {{288-289}},

 note = {{Accessed on 2025/10/10}}}